Role of inflammatory biomarkers in the prevalence and incidence of hypertension among HIV-positive participants in the START trial. Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE for the INSIGHT START study group. 
Am J Hypertens 2020; 33(1):43–52. Abstract